Metabolic Alkalosis in the Pediatric Patient: Treatment Options in the Pediatric ICU or Pediatric Cardiothoracic ICU Setting.

Abstract

Metabolic alkalosis is characterized by the primary elevation of the serum bicarbonate concentration with a normal or elevated partial pressure of carbon dioxide. Although there may be several potential etiologies in the critically ill patient in the pediatric or cardiothoracic intensive care unit, metabolic alkalosis most commonly results from diuretic therapy with chloride loss. In most cases, the etiology can be determined by a review of the patient's history and medication record. Although generally innocuous with limited impact on physiologic function, metabolic alkalosis may impair central control of ventilation, especially when weaning from mechanical ventilation. The following manuscript presents the normal homeostatic mechanisms that control pH, reviews the etiology of metabolic alkalosis, and outlines the differential diagnosis. Options and alternatives for treatment including pharmacologic interventions are presented with a focus on these conditions as they pertain to the patient in the pediatric or cardiac intensive care unit.

• Authors: Joseph D Tobias
• Journal: World journal for pediatric & congenital heart surgery (World J Pediatr Congenit Heart Surg) Vol. 11 Issue 6 Pg. 776-782 (Nov 2020) ISSN: 2150-136X [Electronic] United States
• PMID: 33164684 (Publication Type: Journal Article, Review)

Chemical References

• Bicarbonates
• Carbonic Anhydrase Inhibitors
• Acetazolamide

Topics

• Acetazolamide (therapeutic use)
• Alkalosis (blood, etiology, therapy)
• Bicarbonates (blood)
• Carbonic Anhydrase Inhibitors (therapeutic use)
• Child
• Critical Illness (therapy)
• Humans
• Intensive Care Units, Pediatric (statistics & numerical data)
• Respiration, Artificial (adverse effects)